|Videos|November 26, 2013
Episode 11 - Personalized Medicine in CRPC
Advertisement
Episodes in this series
During this segment, the panelists explore the use of personalized medicine in castration-resistant prostate cancer.
Jeffrey D. Dunn, PharmD, MBA, and Raoul S. Concepcion, MD, explain that clinicians hope to have better data available in the future to provide definitive answers about treatment options for specific patient populations.
Dr Concepcion explains the variables that are being reviewed to help clinicians make wiser treatment decisions for their patients.
However, E. David Crawford, MD, reminds the panelists why achieving this goal will not be easy.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
ATTR-CM Incidence, Prevalence Rose Sharply in the US
3
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance
4
First Generic of Priftin Approved by FDA for Tuberculosis Treatment and Prevention
5